DE602004027014D1 - Ttel und synergistischer kombinationen - Google Patents

Ttel und synergistischer kombinationen

Info

Publication number
DE602004027014D1
DE602004027014D1 DE602004027014T DE602004027014T DE602004027014D1 DE 602004027014 D1 DE602004027014 D1 DE 602004027014D1 DE 602004027014 T DE602004027014 T DE 602004027014T DE 602004027014 T DE602004027014 T DE 602004027014T DE 602004027014 D1 DE602004027014 D1 DE 602004027014D1
Authority
DE
Germany
Prior art keywords
synergistic combinations
ttel
pathway
experimental strategy
novel experimental
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004027014T
Other languages
English (en)
Inventor
Ian R Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synergy Biosystems Ltd
Original Assignee
Synergy Biosystems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergy Biosystems Ltd filed Critical Synergy Biosystems Ltd
Publication of DE602004027014D1 publication Critical patent/DE602004027014D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/06—Methods of screening libraries by measuring effects on living organisms, tissues or cells
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Computing Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Paper (AREA)
  • Threshing Machine Elements (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE602004027014T 2003-03-26 2004-03-24 Ttel und synergistischer kombinationen Expired - Lifetime DE602004027014D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45785903P 2003-03-26 2003-03-26
US45786003P 2003-03-26 2003-03-26
US45786103P 2003-03-26 2003-03-26
US48356403P 2003-06-28 2003-06-28
PCT/US2004/008957 WO2004088272A2 (en) 2003-03-26 2004-03-24 Methods to identify biologically active agents and synergistic combinations

Publications (1)

Publication Number Publication Date
DE602004027014D1 true DE602004027014D1 (de) 2010-06-17

Family

ID=33136181

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004027014T Expired - Lifetime DE602004027014D1 (de) 2003-03-26 2004-03-24 Ttel und synergistischer kombinationen

Country Status (6)

Country Link
US (2) US7264933B2 (de)
EP (1) EP1606759B1 (de)
AT (1) ATE467123T1 (de)
DE (1) DE602004027014D1 (de)
ES (1) ES2343411T3 (de)
WO (1) WO2004088272A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2672408C (en) * 2007-03-30 2019-07-23 9898 Limited Pharmacokinetic and pharmacodynamic modelling and methods for the development of phytocompositions or other multi-component compositions
WO2012040313A1 (en) * 2010-09-21 2012-03-29 Lankenau Institute Of Medical Research Chemical Genomics Center Ultra-high throughput screening methods to detect synergistic drug interactions
EP3044712A4 (de) * 2013-08-23 2017-12-13 Elwha, Llc Modifizierung eines kosmetikprodukts auf basis eines mikrobenprofils
CN105224799B (zh) * 2015-09-30 2018-03-02 中国人民解放军军事医学科学院放射与辐射医学研究所 联用药药效的处理方法和处理装置
CN109115742A (zh) * 2018-09-05 2019-01-01 中国农业科学院农业质量标准与检测技术研究所 一种抗雄激素效应的检测方法
DE102020202529A1 (de) * 2020-02-27 2021-09-02 Robert Bosch Gesellschaft mit beschränkter Haftung Verfahren zur Identifikation einer Wirkstoffkombination

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8928634D0 (en) 1989-12-19 1990-02-21 Unilever Plc Method of testing
US6780596B2 (en) * 1998-09-17 2004-08-24 Ashni Naturaceuticals, Inc. Methods for determining the activity of complex mixtures
AU2001268264A1 (en) * 2000-06-20 2002-01-02 Ortho-Mcneil Pharmaceutical, Inc. Resazurin-based cytotoxicity assay
CZ20024220A3 (cs) 2000-06-30 2003-06-18 Unilever N. V. Prostředek pro péči o pleť
US20020019010A1 (en) 2000-07-07 2002-02-14 Stockwell Brent R. Methods for identifying combinations of entities as therapeutics
US6569853B1 (en) * 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US6693125B2 (en) * 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
WO2002061073A2 (en) * 2001-01-30 2002-08-08 Thomas Jefferson University Mutwnt fish for genetic screebibg of lipid and cholesterol metabolism
KR20040026680A (ko) 2001-07-09 2004-03-31 콤비네이토릭스, 인코포레이티드 염증 질환 치료용 조합
TW573125B (en) 2001-08-29 2004-01-21 Combinatorx Inc A screening system for identifying drug-drug interactions and methods of use thereof
EP1448205B1 (de) 2001-10-05 2011-03-23 Zalicus Inc. Kombinationen für die behandlung von immun-entzündlichen erkrankungen

Also Published As

Publication number Publication date
EP1606759A2 (de) 2005-12-21
WO2004088272A3 (en) 2005-08-18
US20080026400A1 (en) 2008-01-31
WO2004088272A2 (en) 2004-10-14
EP1606759A4 (de) 2007-11-28
ATE467123T1 (de) 2010-05-15
US7264933B2 (en) 2007-09-04
EP1606759B1 (de) 2010-05-05
ES2343411T3 (es) 2010-07-30
US20040203043A1 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
EA200702568A1 (ru) Гетеробициклические ингибиторы металлопротеазы и их применение
NO20100145L (no) Forbindelser med serin-protease-inhiberende virkning, spesielt hepatitt C-NS3-inhiberende virkning
DE60327148D1 (de) Schnelle thermische Behandlung von schweren Kohlenwasserstoffeinsätzen in Anwesenheit von Kalziumverbindungen
ECSP055708A (es) Sales bencenosulfonato de derivadosde 4-fluoro-2-cianopirrolidina
CR9761A (es) Reduccion de celulas b utilizando moleculas de union especificas cd37 y cd20
DE60325567D1 (de) Matrix für die modifizierte freigabe von aktiven substanzen
DE60330541D1 (de) System zum Verfolgen von Poststücken
DE60023266D1 (de) Serinprotease-inhibitoren
DE60329983D1 (de) Wachsestersynthase-dna-sequenz, protein und verwendungen davon
BRPI0600777A (pt) método e sistema para a criação, armazenamento, gerenciamento e consumo de dados especìficos de cultura
NL1023157A1 (nl) Stabilisatormengsels.
EA200800357A1 (ru) Новые фармацевтические соединения
ATE267396T1 (de) Identifizierung von zellen während kinetischer versuchsreihen
ATE555119T1 (de) Expression von proteaseinhibitoren und varianten davon in filamentösen pilzen
RS50671B (sr) Kristalisan polietilen tereftalat, koji sadrži silicijum, i postupak za njegovo dobijanje
ATE475961T1 (de) Kennzeichnungsschildersatz
DE602004027014D1 (de) Ttel und synergistischer kombinationen
BRPI0411988A (pt) substrato para admissão e crioconservação de uma multiplicidade de amostras, respectivos empregos e processo de crioconservação de amostra de substrato
NL1030253A1 (nl) Elektronenmicroscoop.
EA200401032A1 (ru) Антиинфарктные молекулы
JP2013017402A5 (de)
DE10290563D2 (de) Mittel zur Hemmung von Tumorzellen
NO20044186L (no) Peptid-deformylaseinhibitorer
ITPR20030089A1 (it) Valvola di omogeneizzazione.
DE50308413D1 (de) Kontaktierung von nanoröhren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition